“Use of Brexucabtagene Autoleucel in the treatment of Relapsed/refractory Mantle Cell Lymphoma”, Acervo Saúde, vol. 25, no. 6, p. e20837, Jun. 2025, doi: 10.25248/reas.e20837.2025.